Adapting and Assessing the Feasibility of a Diabetes Self-management Telehealth Intervention
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04600622 |
Recruitment Status :
Completed
First Posted : October 23, 2020
Last Update Posted : August 31, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diabetes Mellitus | Behavioral: Rural Diabetes One-Day Education and Care program (R-D1D) Behavioral: Diabetes Education Materials | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 67 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Adapting and Assessing the Feasibility of a Diabetes Self-management Education and Support Telehealth Intervention for Rural Populations to Reduce Disparities in Diabetes Care |
Actual Study Start Date : | June 17, 2021 |
Actual Primary Completion Date : | April 8, 2022 |
Actual Study Completion Date : | August 24, 2022 |

Arm | Intervention/treatment |
---|---|
Experimental: Intervention Arm
Participants will receive Rural Diabetes One-Day Education and Care program (R-D1D). A one time, 5.5-hour multi-disciplinary diabetes self-management education and support intervention delivered via telehealth.
|
Behavioral: Rural Diabetes One-Day Education and Care program (R-D1D)
One time, 5.5-hour multi-disciplinary diabetes self-management education and support intervention delivered via telehealth. |
Active Comparator: Active Comparator
Participants will receive diabetes education materials.
|
Behavioral: Diabetes Education Materials
Diabetes Education Materials |
- Average Acceptability Score [ Time Frame: 3 months ]Average acceptability score on the intervention acceptability measure
- Average Feasibility Score [ Time Frame: 3 months ]Average feasibility score on the feasibility measure
- Change in glycosylated hemoglobin A1C [ Time Frame: Baseline to 3 months ]Physiologic measurement
- Change in diabetes distress score [ Time Frame: Baseline to 3 months ]The patient reported, 20-item, Problem Areas in Diabetes survey will be used.
- Change in Family and Friend Involvement in Diabetes score [ Time Frame: Baseline to 3 months ]The patient reported, 16-item, Family and Friend Involvement in Diabetes survey will be used.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Have a known diagnosis of type 1 or 2 diabetes with any A1C level
- 18 years old or older
- Live in a rural eastern Colorado
- Speak and understand English or Spanish
- Willing to participate in a telehealth intervention at the clinic where they usually receive care or in their own home if an in-person meeting is prohibited due to the pandemic
Exclusion Criteria:
- Are participating in another diabetes study
- Significant cognitive impairment
- Pregnant or planning to become pregnant as diabetes management recommendations are different in pregnancy
- Life expectancy of <6 months
- Plan to move during the time of the study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04600622
United States, Colorado | |
University of Colorado Denver | |
Denver, Colorado, United States, 80204 |
Principal Investigator: | Michelle L Litchman, PhD | University of Utah College of Nursing | |
Principal Investigator: | Tamara K Oser, MD | University of Colorado, Denver |
Responsible Party: | Michelle Litchman, Assistant Profesor, University of Utah |
ClinicalTrials.gov Identifier: | NCT04600622 |
Other Study ID Numbers: |
00133179 |
First Posted: | October 23, 2020 Key Record Dates |
Last Update Posted: | August 31, 2023 |
Last Verified: | August 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
diabetes telehealth rural |
Spanish English community based participatory research |
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |